SCHEMBL9385189

SCHEMBL9385189

CC(=O)Oc1ccc2c(c1OC(C)=O)CNC(C(=O)O)C2

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.38
DRD2 P14416 3/20 0.38
DRD1 P21728 3/20 0.38
EGLN1 Q9GZT9 1/20 0.37
F3 P13726 1/20 0.36
GRIA2 P42262 1/20 0.35
GAA P10253 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 2/20 0.33
CFD P00746 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9389470 0.87 MAPT (0.43) MAPK1DRD2DRD1F3GAA
SCHEMBL9205461 0.76 MAPK1 (0.41) MAPK1DRD2DRD1GAAKDM4E
SCHEMBL50939 0.70 HTR1A (0.43) MAPK1DRD2DRD1F3MAPT
SCHEMBL50569 0.70 HTR1A (0.43) MAPK1DRD2DRD1F3MAPT
SCHEMBL23036790 0.70 EGLN1 (0.44) DRD2DRD1EGLN1GRIA2GAA
SCHEMBL31369369 0.69 EGLN1 (0.43) EGLN1GRIA2GAAMAPT
SCHEMBL8964041 0.68 GRIA2 (0.39) DRD2DRD1EGLN1F3GRIA2
SCHEMBL8964416 0.68 GRIA2 (0.39) DRD2DRD1EGLN1F3GRIA2
SCHEMBL9548214 0.67 GAA (0.46) DRD2EGLN1GRIA2GAAMAPT
SCHEMBL9543916 0.67 ANPEP (0.44) MAPK1EGLN1GRIA2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994003432-A1 POLYHYDROXYLATED NAPHTHYL 2-CARBOXYLATE, AND QUINOLYL AND ISOQUINOLYL 3-CARBOXYLATE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-02-17 WO disclosed